Literature DB >> 2104894

Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-gamma production.

G R Klimpel1, C R Annable, M G Cleveland, T R Jerrells, J C Patterson.   

Abstract

We have previously shown that both IFN-gamma and IFN-beta are produced in vivo and in vitro by spleen cells obtained from mice experiencing a chronic form of graft vs host disease (GVHD). Further, we have shown that in vitro production of IFN-beta by spleen cells from GVHD mice may play a role in the suppressed in vitro mitogen responsiveness of these cells. This study was undertaken to investigate if treatment of such mice with mAb to IFN-gamma or IFN-beta could alter the immunosuppression or lymphoid hypoplasia associated with chronic GVHD. GVHD was induced across minor histocompatibilities by the i.v. injection of B10.D2 spleen cells into sublethally irradiated BALB/c mice. These mice were given daily injections for 20 days of one of the following: 1) mAb to IFN-gamma, 2) mAb to IFN-beta, or 3) control IgG. Histologic examination of these mice at 21 to 22 days post transplantation revealed that mice treated with mAb to IFN-beta or control IgG had dramatic hypoplasia of the thymus, spleen, and lymph nodes which was similar to untreated GVHD mice. Mice given mAb to IFN-gamma, however, had no lymphoid hypoplasia and had a near normal gross and histologic appearance of their thymus, spleen, and lymph node tissue when compared with syngeneic controls. In vitro mitogen-induced proliferative responses of spleen and lymph node cells obtained from GVHD mice or GVHD mice treated with mAb to IFN-beta were severely suppressed or absent. In contrast, spleen and lymph node cells from GVHD mice given mAb to IFN-gamma were capable of giving a significant in vitro proliferative response to Con A, PHA, and LPS. Further, natural suppressor cell activity and spontaneous production of IFN-beta, a characteristic of this form of GVHD, was absent in spleen cells obtained from GVHD mice treated with mAb to IFN-gamma. These results further identify the IFN as playing critical roles in the pathogenesis of GVHD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104894

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation.

Authors:  Wannee Asavaroengchai; Hui Wang; Shumei Wang; Lan Wang; Roderick Bronson; Megan Sykes; Yong-Guang Yang
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

2.  Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function.

Authors:  M B Baker; R L Riley; E R Podack; R B Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Effects of intrabone marrow-bone marrow transplantation plus adult thymus transplantation on survival of mice bearing leukemia.

Authors:  Yuming Zhang; Naoki Hosaka; Yunze Cui; Ming Shi; Ming Li; Qing Li; Susumu Ikehara
Journal:  Stem Cells Dev       Date:  2011-10-19       Impact factor: 3.272

4.  Neutralization of interferon-gamma exacerbates pneumocystis-driven interstitial pneumonitis after bone marrow transplantation in mice.

Authors:  B A Garvy; F Gigliotti; A G Harmsen
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

Authors:  Y G Yang; B R Dey; J J Sergio; D A Pearson; M Sykes
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

6.  Purified hematopoietic stem cell allografts reconstitute immunity superior to bone marrow.

Authors:  Gabriel J Tsao; Jessica A Allen; Kathryn A Logronio; Laura C Lazzeroni; Judith A Shizuru
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-17       Impact factor: 11.205

Review 7.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

8.  The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice.

Authors:  M B Baker; N H Altman; E R Podack; R B Levy
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

9.  T cell and non-T cell compartments can independently determine resistance to Leishmania major.

Authors:  A H Shankar; R G Titus
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

10.  Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.

Authors:  F P Nestel; K S Price; T A Seemayer; W S Lapp
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.